All Industries

Top Biotech Companies

5,081 Biotech companies, sorted by total funding raised.

GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate Round·$835.0M·Jun 2026
Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech, Oncology
Series B·$832.0M·Sep 2025
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension Round·$821.8M·Sep 2025
Cardurion

Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and ...

Burlington, United States11–50Biotech, Healthcare
Series B·$820.0M·Jul 2024
Enveda

Biotechnology company using AI to learn from life's chemistry and discover medicines 4X faster.

Boulder, United States201–500Biotech, Artificial Intelligence
Series D·$815.0M·Sep 2025
Parabilis MedicinesIPO

Precision medicine company pursuing previously undruggable disease targets using novel therapeuti...

Cambridge, United States201–500Biotech, Life Sciences
Series F·$812.0M·Jan 2026
Spiber

Japanese biotech company developing fermented Brewed Protein materials for sustainable textiles a...

Tokyo, Japan201–500Biotech, Manufacturing
Venture Round·$807.6M·Dec 2024
FogPharma

Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...

Cambridge, United States51–200Biotech, Drug Discovery
Series F·$801.0M·Jan 2025
Perfect Day

Sustainable dairy protein from precision fermentation

Berkeley, United States51–200Biotech
Series E·$787.7M·Jan 2024
XtalPiIPO

AI and quantum physics-powered drug discovery platform accelerating pharmaceutical R&D through cr...

Beijing, China1001–5000Biotech, Artificial Intelligence
Series D·$785.1M·Jan 2021
TheranosClosed

Blood testing technology company claiming miniaturized diagnostics

Palo Alto, United States501–1000Biotech, Healthcare
Venture Round·$750.0M·Jun 2014
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate Round·$730.0M·Dec 2025
Beeline Medicines

Clinical-stage biotechnology company developing precision therapies for autoimmune diseases.

Boston, United StatesBiotech, Healthcare
Series A·$726.3M·Jul 2026
EQRxClosed

Developing new medicines with the goal of expanding global access for patients

Cambridge, United States51–200Healthcare, Biotech
Series B·$700.0M·Jan 2021
Odyssey TherapeuticsIPO

Clinical-stage biopharmaceutical company developing small molecule and protein therapeutics for a...

Boston, United States51–200Biotech, Healthcare
Series D·$700.0M·Sep 2025
ImmunicIPO

Late-stage biotechnology company developing novel selective oral immunology therapies for chronic...

New York, United StatesBiotech, Healthcare
Private Equity·$694.9M·Feb 2026
Generate BiomedicinesIPO

AI-powered generative biology platform creating novel protein therapeutics across antibodies, pep...

Cambridge, United States201–500Artificial Intelligence, Biotech
Corporate Round·$693.0M·Dec 2024
Gossamer BioIPO

Biopharmaceutical company developing seralutinib for the treatment of pulmonary arterial hyperten...

San Diego, United States51–200Biotech, Healthcare
Private Equity·$662.0M·Jul 2023
Kriya Therapeutics

Kriya Therapeutics develops one-time gene therapies for chronic common diseases.

Research Triangle Park, United StatesBiotech, Healthcare
Series D·$655.0M·Sep 2025
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series B·$650.0M·Oct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private Equity·$647.0M·Feb 2026
Solugen

Decarbonizing the chemicals industry.

Houston, United States51–200Biotech, Climate Tech
Venture Round·$645.7M·Mar 2026
Celularity

Celularity is a biotechnology company developing off-the-shelf placental-derived allogeneic cell ...

Florham Park, United States51–200Biotech, Healthcare
Extension Round·$645.0M·Jan 2021
insitro

High-quality perturbational data generation and AI to discover new targets and enable drug discov...

South San Francisco, United States201–500Artificial Intelligence, Healthcare
Series C·$643.0M·Mar 2021
Insilico MedicineIPO

AI-driven drug discovery company using generative AI and deep learning to design novel drug candi...

Hong Kong, Hong Kong201–500Artificial Intelligence, Biotech
Series E·$632.8M·Mar 2026